@article{84505127397e463598584f4c33739a78,
title = "Estimating residual kidney function in dialysis patients without urine collection",
abstract = "Residual kidney function contributes substantially to solute clearance in dialysis patients but cannot be assessed without urine collection. We used serum filtration markers to develop dialysis-specific equations to estimate urinary urea clearance without the need for urine collection. In our development cohort, we measured 24-hour urine clearances under close supervision in 44 patients and validated these equations in 826 patients from the Netherlands Cooperative Study on the Adequacy of Dialysis. For the development and validation cohorts, median urinary urea clearance was 2.6 and 2.4 ml/min, respectively. During the 24-hour visit in the development cohort, serum β-trace protein concentrations remained in steady state but concentrations of all other markers increased. In the validation cohort, bias (median measured minus estimated clearance) was low for all equations. Precision was significantly better for β-trace protein and β2-microglobulin equations and the accuracy was significantly greater for β-trace protein, β2-microglobulin, and cystatin C equations, compared with the urea plus creatinine equation. Area under the receiver operator characteristic curve for detecting measured urinary urea clearance by equation-estimated urinary urea clearance (both 2 ml/min or more) were 0.821, 0.850, and 0.796 for β-trace protein, β2-microglobulin, and cystatin C equations, respectively; significantly greater than the 0.663 for the urea plus creatinine equation. Thus, residual renal function can be estimated in dialysis patients without urine collections.",
keywords = "hemodialysis, peritoneal dialysis, residual kidney function",
author = "Tariq Shafi and Michels, {Wieneke M.} and Levey, {Andrew S.} and Inker, {Lesley A.} and Dekker, {Friedo W.} and Krediet, {Raymond T.} and Tiny Hoekstra and Schwartz, {George J.} and Eckfeldt, {John H.} and Josef Coresh",
note = "Funding Information: TS is supported by grant no. K23-DK-083514 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health and has received speaker fees from Siemens. ASL has received funding paid to Tufts Medical Center for research and contracts with the National Institutes of Health, National Kidney Foundation, Amgen, Pharmalink AB, Gilead Sciences; and has a provisional patent filed 15 August 2014—Precise estimation of glomerular filtration rate from multiple biomarkers (licensing under negotiation). LAI has received funding paid to Tufts Medical Center for research and contracts with the National Institutes of Health, National Kidney Foundation, Pharmalink AB, and Gilead Sciences; has a consulting agreement with Otsuka; and has a provisional patent filed 15 August 2014—Precise estimation of glomerular filtration rate from multiple biomarkers (licensing under negotiation). JHE is a consultant for Gentian, which is a Norwegian manufacturer of reagents for clinical cystatin C measurement procedures, and his research laboratory has received free or steeply discounted reagents from Siemens for measurement of β-trace protein, cystatin C, and β-2 microglobulin. JC has a provisional patent filed 15 August 2014—Precise estimation of glomerular filtration rate from multiple biomarkers (licensing under negotiation). All the other authors declared no competing interests. Funding Information: Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2016 International Society of Nephrology.",
year = "2016",
month = may,
day = "1",
doi = "10.1016/j.kint.2015.10.011",
language = "English (US)",
volume = "89",
pages = "1099--1110",
journal = "Kidney international",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",
}